Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Dose-Response on DPP-4 Activity
NCT02192853Phase 4Completed
- Sponsor
- Gentofte Hospital
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin with Placebo (2 arms). Primary endpoint: Correlation between total and intact GLP-1 hormone. Started May 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02192853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192853.